ヒストンデアセチラーゼ（HDAC）阻害剤の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Histone Deacetylase (HDAC) Inhibitors Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C2780
• 出版社/出版日：GlobalInfoResearch / 2019年8月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、116ページ
• 納品方法：Eメール
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、ヒストンデアセチラーゼ（HDAC）阻害剤の世界市場について調べ、まとめました。種類別セグメントは、脂肪酸、ヒドロキサメート、環状ペプチド、ベンズアミド等、用途別セグメントは、悪性腫瘍治療、慢性疾患治療、その他等に区分しました。ヒストンデアセチラーゼ（HDAC）阻害剤の世界市場概観、企業動向、企業別ヒストンデアセチラーゼ（HDAC）阻害剤シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・ヒストンデアセチラーゼ（HDAC）阻害剤の市場概観
・ヒストンデアセチラーゼ（HDAC）阻害剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・ヒストンデアセチラーゼ（HDAC）阻害剤の企業別販売動向、市場シェア、市場集中度、競争動向
・ヒストンデアセチラーゼ（HDAC）阻害剤の世界市場規模
・ヒストンデアセチラーゼ（HDAC）阻害剤の北米市場分析（アメリカ、カナダ、メキシコ等）
・ヒストンデアセチラーゼ（HDAC）阻害剤のアメリカ市場規模推移
・ヒストンデアセチラーゼ（HDAC）阻害剤のカナダ市場規模推移
・ヒストンデアセチラーゼ（HDAC）阻害剤のメキシコ市場規模推移
・ヒストンデアセチラーゼ（HDAC）阻害剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・ヒストンデアセチラーゼ（HDAC）阻害剤のドイツ市場規模推移
・ヒストンデアセチラーゼ（HDAC）阻害剤のイギリス市場規模推移
・ヒストンデアセチラーゼ（HDAC）阻害剤のロシア市場規模推移
・ヒストンデアセチラーゼ（HDAC）阻害剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・ヒストンデアセチラーゼ（HDAC）阻害剤の日本市場規模推移
・ヒストンデアセチラーゼ（HDAC）阻害剤の中国市場規模推移
・ヒストンデアセチラーゼ（HDAC）阻害剤の韓国市場規模推移
・ヒストンデアセチラーゼ（HDAC）阻害剤のインド市場規模推移
・ヒストンデアセチラーゼ（HDAC）阻害剤の東南アジア市場規模推移
・ヒストンデアセチラーゼ（HDAC）阻害剤の南米市場分析（ブラジル、アルゼンチン等）
・ヒストンデアセチラーゼ（HDAC）阻害剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・ヒストンデアセチラーゼ（HDAC）阻害剤の種類別分析/販売量、売上、市場シェア（脂肪酸、ヒドロキサメート、環状ペプチド、ベンズアミド）
・ヒストンデアセチラーゼ（HDAC）阻害剤の用途別分析/市場規模（悪性腫瘍治療、慢性疾患治療、その他）
・ヒストンデアセチラーゼ（HDAC）阻害剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・ヒストンデアセチラーゼ（HDAC）阻害剤の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The worldwide market for Histone Deacetylase (HDAC) Inhibitors is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Histone Deacetylase (HDAC) Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
4SC
Acetylon Pharmaceuticals
Celleron Therapeutics
Chipscreen Biosciences
Chroma Therapeutics
CrystalGenomics
Curis
MEI Pharma
Mirati Therapeutics
Novartis
Onxeo
Repligen
TetraLogic

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Fatty Acid
Hydroxamate
Cyclic Peptide
Benzamide

Market Segment by Applications, can be divided into
Treatment of Malignant Tumors
Chronic Disease Treatment
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Histone Deacetylase (HDAC) Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Histone Deacetylase (HDAC) Inhibitors, with price, sales, revenue and global market share of Histone Deacetylase (HDAC) Inhibitors in 2017 and 2018.
Chapter 3, the Histone Deacetylase (HDAC) Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Histone Deacetylase (HDAC) Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Histone Deacetylase (HDAC) Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Histone Deacetylase (HDAC) Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Histone Deacetylase (HDAC) Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Fatty Acid
1.2.2 Hydroxamate
1.2.3 Cyclic Peptide
1.2.4 Benzamide
1.3 Market Analysis by Applications
1.3.1 Treatment of Malignant Tumors
1.3.2 Chronic Disease Treatment
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 4SC
2.1.1 Business Overview
2.1.2 Histone Deacetylase (HDAC) Inhibitors Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 4SC Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Acetylon Pharmaceuticals
2.2.1 Business Overview
2.2.2 Histone Deacetylase (HDAC) Inhibitors Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Celleron Therapeutics
2.3.1 Business Overview
2.3.2 Histone Deacetylase (HDAC) Inhibitors Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Chipscreen Biosciences
2.4.1 Business Overview
2.4.2 Histone Deacetylase (HDAC) Inhibitors Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Chroma Therapeutics
2.5.1 Business Overview
2.5.2 Histone Deacetylase (HDAC) Inhibitors Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 CrystalGenomics
2.6.1 Business Overview
2.6.2 Histone Deacetylase (HDAC) Inhibitors Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Curis
2.7.1 Business Overview
2.7.2 Histone Deacetylase (HDAC) Inhibitors Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Curis Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 MEI Pharma
2.8.1 Business Overview
2.8.2 Histone Deacetylase (HDAC) Inhibitors Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Mirati Therapeutics
2.9.1 Business Overview
2.9.2 Histone Deacetylase (HDAC) Inhibitors Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Novartis
2.10.1 Business Overview
2.10.2 Histone Deacetylase (HDAC) Inhibitors Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novartis Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Onxeo
2.11.1 Business Overview
2.11.2 Histone Deacetylase (HDAC) Inhibitors Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Onxeo Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Repligen
2.12.1 Business Overview
2.12.2 Histone Deacetylase (HDAC) Inhibitors Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Repligen Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 TetraLogic
2.13.1 Business Overview
2.13.2 Histone Deacetylase (HDAC) Inhibitors Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Histone Deacetylase (HDAC) Inhibitors Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Histone Deacetylase (HDAC) Inhibitors Manufacturer Market Share in 2018
3.3.2 Top 6 Histone Deacetylase (HDAC) Inhibitors Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Histone Deacetylase (HDAC) Inhibitors Market Analysis by Regions
4.1 Global Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Market Share by Regions
4.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales and Market Share by Regions (2014-2019)
4.1.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue and Market Share by Regions (2014-2019)
4.2 North America Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
4.3 Europe Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
4.5 South America Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
5 North America Histone Deacetylase (HDAC) Inhibitors by Country
5.1 North America Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Market Share by Country
5.1.1 North America Histone Deacetylase (HDAC) Inhibitors Sales and Market Share by Country (2014-2019)
5.1.2 North America Histone Deacetylase (HDAC) Inhibitors Revenue and Market Share by Country (2014-2019)
5.2 United States Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
5.3 Canada Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
5.4 Mexico Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
6 Europe Histone Deacetylase (HDAC) Inhibitors by Country
6.1 Europe Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Market Share by Country
6.1.1 Europe Histone Deacetylase (HDAC) Inhibitors Sales and Market Share by Country (2014-2019)
6.1.2 Europe Histone Deacetylase (HDAC) Inhibitors Revenue and Market Share by Country (2014-2019)
6.2 Germany Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
6.3 UK Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
6.4 France Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
6.5 Russia Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
6.6 Italy Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
7 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors by Country
7.1 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Revenue and Market Share by Country (2014-2019)
7.2 China Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
7.3 Japan Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
7.4 Korea Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
7.5 India Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
8 South America Histone Deacetylase (HDAC) Inhibitors by Country
8.1 South America Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Market Share by Country
8.1.1 South America Histone Deacetylase (HDAC) Inhibitors Sales and Market Share by Country (2014-2019)
8.1.2 South America Histone Deacetylase (HDAC) Inhibitors Revenue and Market Share by Country (2014-2019)
8.2 Brazil Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
8.3 Argentina Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
8.4 Colombia Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
9 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors by Countries
9.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
9.3 Turkey Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
9.4 Egypt Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
9.5 Nigeria Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
9.6 South Africa Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
10 Global Histone Deacetylase (HDAC) Inhibitors Market Segment by Type
10.1 Global Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales and Market Share by Type (2014-2019)
10.1.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue and Market Share by Type (2014-2019)
10.2 Fatty Acid Sales Growth and Price
10.2.1 Global Fatty Acid Sales Growth (2014-2019)
10.2.2 Global Fatty Acid Price (2014-2019)
10.3 Hydroxamate Sales Growth and Price
10.3.1 Global Hydroxamate Sales Growth (2014-2019)
10.3.2 Global Hydroxamate Price (2014-2019)
10.4 Cyclic Peptide Sales Growth and Price
10.4.1 Global Cyclic Peptide Sales Growth (2014-2019)
10.4.2 Global Cyclic Peptide Price (2014-2019)
10.5 Benzamide Sales Growth and Price
10.5.1 Global Benzamide Sales Growth (2014-2019)
10.5.2 Global Benzamide Price (2014-2019)
11 Global Histone Deacetylase (HDAC) Inhibitors Market Segment by Application
11.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2014-2019)
11.2 Treatment of Malignant Tumors Sales Growth (2014-2019)
11.3 Chronic Disease Treatment Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Histone Deacetylase (HDAC) Inhibitors Market Forecast (2019-2024)
12.1 Global Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Growth Rate (2019-2024)
12.2 Histone Deacetylase (HDAC) Inhibitors Market Forecast by Regions (2019-2024)
12.2.1 North America Histone Deacetylase (HDAC) Inhibitors Market Forecast (2019-2024)
12.2.2 Europe Histone Deacetylase (HDAC) Inhibitors Market Forecast (2019-2024)
12.2.3 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Market Forecast (2019-2024)
12.2.4 South America Histone Deacetylase (HDAC) Inhibitors Market Forecast (2019-2024)
12.2.5 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Forecast (2019-2024)
12.3 Histone Deacetylase (HDAC) Inhibitors Market Forecast by Type (2019-2024)
12.3.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Type (2019-2024)
12.3.2 Global Histone Deacetylase (HDAC) Inhibitors Market Share Forecast by Type (2019-2024)
12.4 Histone Deacetylase (HDAC) Inhibitors Market Forecast by Application (2019-2024)
12.4.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Application (2019-2024)
12.4.2 Global Histone Deacetylase (HDAC) Inhibitors Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Histone Deacetylase (HDAC) Inhibitors Picture
Table Product Specifications of Histone Deacetylase (HDAC) Inhibitors
Figure Global Sales Market Share of Histone Deacetylase (HDAC) Inhibitors by Types in 2018
Table Histone Deacetylase (HDAC) Inhibitors Types for Major Manufacturers
Figure Fatty Acid Picture
Figure Hydroxamate Picture
Figure Cyclic Peptide Picture
Figure Benzamide Picture
Figure Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Applications in 2018
Figure Treatment of Malignant Tumors Picture
Figure Chronic Disease Treatment Picture
Figure Other Picture
Figure United States Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure France Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure UK Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure China Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure India Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Histone Deacetylase (HDAC) Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Table 4SC Basic Information, Manufacturing Base and Competitors
Table 4SC Histone Deacetylase (HDAC) Inhibitors Type and Applications
Table 4SC Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Acetylon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Type and Applications
Table Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Celleron Therapeutics Basic Information, Manufacturing Base and Competitors
Table Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Type and Applications
Table Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Chipscreen Biosciences Basic Information, Manufacturing Base and Competitors
Table Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Type and Applications
Table Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Chroma Therapeutics Basic Information, Manufacturing Base and Competitors
Table Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Type and Applications
Table Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CrystalGenomics Basic Information, Manufacturing Base and Competitors
Table CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Type and Applications
Table CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Curis Basic Information, Manufacturing Base and Competitors
Table Curis Histone Deacetylase (HDAC) Inhibitors Type and Applications
Table Curis Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table MEI Pharma Basic Information, Manufacturing Base and Competitors
Table MEI Pharma Histone Deacetylase (HDAC) Inhibitors Type and Applications
Table MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Mirati Therapeutics Basic Information, Manufacturing Base and Competitors
Table Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Type and Applications
Table Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Histone Deacetylase (HDAC) Inhibitors Type and Applications
Table Novartis Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Onxeo Basic Information, Manufacturing Base and Competitors
Table Onxeo Histone Deacetylase (HDAC) Inhibitors Type and Applications
Table Onxeo Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Repligen Basic Information, Manufacturing Base and Competitors
Table Repligen Histone Deacetylase (HDAC) Inhibitors Type and Applications
Table Repligen Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table TetraLogic Basic Information, Manufacturing Base and Competitors
Table TetraLogic Histone Deacetylase (HDAC) Inhibitors Type and Applications
Table TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Histone Deacetylase (HDAC) Inhibitors Sales by Manufacturer (2017-2018)
Figure Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturer in 2017
Figure Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturer in 2018
Table Global Histone Deacetylase (HDAC) Inhibitors Revenue by Manufacturer (2017-2018)
Figure Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Manufacturer in 2017
Figure Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Manufacturer in 2018
Figure Top 3 Histone Deacetylase (HDAC) Inhibitors Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Histone Deacetylase (HDAC) Inhibitors Manufacturer (Revenue) Market Share in 2018
Figure Global Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Global Histone Deacetylase (HDAC) Inhibitors Revenue and Growth Rate (2014-2019)
Table Global Histone Deacetylase (HDAC) Inhibitors Sales by Regions (2014-2019)
Table Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Regions (2014-2019)
Table Global Histone Deacetylase (HDAC) Inhibitors Revenue by Regions (2014-2019)
Figure Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Regions in 2014
Figure Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Regions in 2018
Figure North America Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Europe Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure South America Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure North America Histone Deacetylase (HDAC) Inhibitors Revenue and Growth Rate (2014-2019)
Table North America Histone Deacetylase (HDAC) Inhibitors Sales by Countries (2014-2019)
Table North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Countries (2014-2019)
Figure North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Countries in 2014
Figure North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Countries in 2018
Table North America Histone Deacetylase (HDAC) Inhibitors Revenue by Countries (2014-2019)
Table North America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Countries in 2014
Figure North America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Countries in 2018
Figure United States Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Canada Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Mexico Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Europe Histone Deacetylase (HDAC) Inhibitors Revenue and Growth Rate (2014-2019)
Table Europe Histone Deacetylase (HDAC) Inhibitors Sales by Countries (2014-2019)
Table Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Countries (2014-2019)
Table Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Countries (2014-2019)
Figure Europe Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Countries in 2017
Figure Europe Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Countries in 2018
Figure Germany Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure UK Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure France Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Russia Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Italy Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Countries (2014-2019)
Table Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Countries 2018
Table Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Countries (2014-2019)
Figure Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Countries 2018
Figure China Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Japan Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Korea Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure India Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Southeast Asia Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure South America Histone Deacetylase (HDAC) Inhibitors Revenue and Growth Rate (2014-2019)
Table South America Histone Deacetylase (HDAC) Inhibitors Sales by Countries (2014-2019)
Table South America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Countries (2014-2019)
Figure South America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Countries in 2018
Table South America Histone Deacetylase (HDAC) Inhibitors Revenue by Countries (2014-2019)
Table South America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure South America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Countries in 2018
Figure Brazil Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Argentina Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Colombia Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Countries (2014-2019)
Table Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Countries in 2018
Table Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Countries (2014-2019)
Table Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Countries in 2014
Figure Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Countries in 2018
Figure Saudi Arabia Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure UAE Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Egypt Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure Nigeria Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Figure South Africa Histone Deacetylase (HDAC) Inhibitors Sales and Growth Rate (2014-2019)
Table Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2014-2019)
Table Global Histone Deacetylase (HDAC) Inhibitors Sales Share by Type (2014-2019)
Table Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2014-2019)
Table Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Type (2014-2019)
Figure Global Fatty Acid Sales Growth (2014-2019)
Figure Global Fatty Acid Price (2014-2019)
Figure Global Hydroxamate Sales Growth (2014-2019)
Figure Global Hydroxamate Price (2014-2019)
Figure Global Cyclic Peptide Sales Growth (2014-2019)
Figure Global Cyclic Peptide Price (2014-2019)
Figure Global Benzamide Sales Growth (2014-2019)
Figure Global Benzamide Price (2014-2019)
Table Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2014-2019)
Table Global Histone Deacetylase (HDAC) Inhibitors Sales Share by Application (2014-2019)
Figure Global Chronic Disease Treatment Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Growth Rate (2019-2024)
Table Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Regions (2019-2024)
Table Global Histone Deacetylase (HDAC) Inhibitors Market Share Forecast by Regions (2019-2024)
Figure North America Sales Histone Deacetylase (HDAC) Inhibitors Market Forecast (2019-2024)
Figure Europe Sales Histone Deacetylase (HDAC) Inhibitors Market Forecast (2019-2024)
Figure Asia-Pacific Sales Histone Deacetylase (HDAC) Inhibitors Market Forecast (2019-2024)
Figure South America Sales Histone Deacetylase (HDAC) Inhibitors Market Forecast (2019-2024)
Figure Middle East and Africa Sales Histone Deacetylase (HDAC) Inhibitors Market Forecast (2019-2024)
Table Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Type (2019-2024)
Table Global Histone Deacetylase (HDAC) Inhibitors Market Share Forecast by Type (2019-2024)
Table Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Application (2019-2024)
Table Global Histone Deacetylase (HDAC) Inhibitors Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List

以下、関連資料のご紹介

世界のヒストンデアセチラーゼ8市場2019

Global Histone Deacetylase 8 Sales Market Report 2019
QYR9N1667 2019年6月10日 108Pages
本調査レポートでは、ヒストンデアセチラーゼ8の世界市場について調査・分析し、ヒストンデアセチラーゼ8のメーカー別販売量、市場シェア分析、種類別販売分析（HG-3001、ラルガゾール、NBM-01、その他）、用途別販売分析（濾胞性リンパ腫、肺がん、肝線維症、その他）、地域別販売分析（米国、ヨーロッパ、...

ヒストンデアセチラーゼ2市場：世界及び中国市場分析・予測（～2024年）

Histone Deacetylase 2 Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9J00689 2019年7月 147Pages
世界及び中国におけるヒストンデアセチラーゼ2市場について調査・分析したレポートで、ヒストンデアセチラーゼ2の世界市場動向、市場規模、主要企業情報などが含まれています。ヒストンデアセチラーゼ2の種類別には、RCY-1305、HG-3001、CS-3158、ACY-957、その他に分けて分析し、地域別に...

低用量ハイドレート阻害剤の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Low dosage Hydrate Inhibitors Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C3466 2019年8月 123Pages
本調査レポートは、低用量ハイドレート阻害剤の世界市場について調べ、まとめました。種類別セグメントは、抗凝集（AA）防止剤、キネティックハイドレート防止剤（KHI）等、用途別セグメントは、陸上、海洋等に区分しました。低用量ハイドレート阻害剤の世界市場概観、企業動向、企業別低用量ハイドレート阻害剤シェア...

燃料腐食防止剤の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Fuel Corrosion Inhibitors Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C2442 2019年8月 115Pages
本調査レポートは、燃料腐食防止剤の世界市場について調べ、まとめました。種類別セグメントは、タイプⅠ、タイプⅡ等、用途別セグメントは、ディーゼル、ガソリン、航空、その他等に区分しました。燃料腐食防止剤の世界市場概観、企業動向、企業別燃料腐食防止剤シェア、市場規模推移、市場規模予測（2019年-2024...

低用量ハイドレート阻害剤(LDHI)の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Low Dosage Hydrate Inhibitors (LDHI) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C3467 2019年8月 116Pages
本調査レポートは、低用量ハイドレート阻害剤(LDHI)の世界市場について調べ、まとめました。種類別セグメントは、抗凝集（AA）防止剤、キネティックハイドレート防止剤（KHI）、その他等、用途別セグメントは、陸上、海洋等に区分しました。低用量ハイドレート阻害剤(LDHI)の世界市場概観、企業動向、企業...

イソクエン酸デヒドロゲナーゼ阻害剤の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Isocitrate Dehydrogenase Inhibitors Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C3165 2019年8月 101Pages
本調査レポートは、イソクエン酸デヒドロゲナーゼ阻害剤の世界市場について調べ、まとめました。種類別セグメントは、IDH1変異型髄様悪性腫瘍、IDH2変異型髄様悪性腫瘍、その他等、用途別セグメントは、DH阻害剤、FLT3阻害剤、ハリネズミ経路阻害剤、その他等に区分しました。イソクエン酸デヒドロゲナーゼ阻...

多発性骨髄腫用標的治療薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Targeted Drugs for Multiple Myeloma Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5677 2019年8月 136Pages
本調査レポートは、多発性骨髄腫用標的治療薬の世界市場について調べ、まとめました。種類別セグメントは、免疫調節剤、プロテアソーム阻害剤、ヒストンデアセチラーゼ阻害剤（HDACI）、モノクローナル抗体、その他等、用途別セグメントは、異種LAN、LAN及びWAN相互接続、WAN及びWAN相互接続、LAN及...

NSCLC用標的薬物MEK阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Targeted Drug MEK Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5672 2019年7月 109Pages
本調査レポートは、NSCLC用標的薬物MEK阻害剤の世界市場について調べ、まとめました。種類別セグメントは、トラメチニブ、その他等、用途別セグメントは、等に区分しました。NSCLC用標的薬物MEK阻害剤の世界市場概観、企業動向、企業別NSCLC用標的薬物MEK阻害剤シェア、市場規模推移、市場規模予測...

NSCLC用標的薬剤VEGFR2阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5675 2019年7月 107Pages
本調査レポートは、NSCLC用標的薬剤VEGFR2阻害剤の世界市場について調べ、まとめました。種類別セグメントは、ラムシルマブ、その他等、用途別セグメントは、等に区分しました。NSCLC用標的薬剤VEGFR2阻害剤の世界市場概観、企業動向、企業別NSCLC用標的薬剤VEGFR2阻害剤シェア、市場規模...

多発性骨髄腫プロテアソーム阻害薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Proteasome Inhibitors for Multiple Myeloma Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4758 2019年8月 109Pages
本調査レポートは、多発性骨髄腫プロテアソーム阻害薬の世界市場について調べ、まとめました。種類別セグメントは、ボルテゾミブ、カルフィルゾミブ、イキサゾミブ、その他等、用途別セグメントは、ものづくり、ヘルスケア、輸送、情報通信、エネルギー・ユーティリティ、その他等に区分しました。多発性骨髄腫プロテアソー...

世界の多発性骨髄腫の治療市場：市場規模・現状・予測 Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. Plasma cells helps to fight infections by making antibodies that recognize and attack germs. Multiple myeloma causes cancer cells to acc…
菌状息肉腫治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Mycosis Fungoides Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Chin…
世界のヒストンデアセチラーゼ8市場2019 The global Histone Deacetylase 8 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Histone Deacetylase 8 market status and forecast, categorizes the global Histone Deacetylase 8 market size (v…
ヒストンデアセチラーゼ2市場：世界及び中国市場分析・予測（～2024年） Histone Deacetylase 2 Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Histone Deacetylase 2 industry with a focus on the Chinese market. The report provides key statistics on the market status of the Histone Deacetylase 2 manu…
リソソーム酸リパーゼ欠乏症（LAAL）治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Lysosomal Acid Lipase Deficiency (LAAL) Treatment market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especi…